Haemonetics Corporation (HAE)

NYSE

$121.69

$-0.34

(-0.28%)

After-Hours

Haemonetics Corporation (HAE) Live Price Chart

Last updated: ⁦2026-10-13 21:28:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Haemonetics Corporation (HAE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $121.69, with a market capitalisation of $5.40B and a P/E ratio of 57.68. Over the past 52 weeks, its price has ranged from $48.55 to $124.04. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$5.40B
Open	$122.80
Day's High	$142.11
Day's Low	$10.85
Previous Close	$122.06
Volume	685.78K
Average Volume	732.61K
P/E Ratio	57.68
52-Week High	$124.04
52-Week Low	$48.55
Dividend Yield	--
Earnings Date	--

Haemonetics Corporation (HAE) After-Hours Stock Price

Haemonetics Corporation (HAE) is trading at $121.68 in after-hours trading as of 2026-10-13 21:24:00, down 0.32% ($0.39) from the regular-session close of $122.06.

After-hours trading shows how investors are pricing HAE after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.

Haemonetics Corporation (HAE) 7-Day Stock Price Change

Over the past seven days, Haemonetics Corporation (HAE) moved from $104.68 to $121.69, representing a gain of 16.25% ($17.01).

The stock traded between $101.32 and $124.04 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 1.01 million shares, up versus the previous seven-day period, indicating higher trading activity.

HAE 52-Week Price Position

Position in Range: 96.9%

52W Low$48.55

52W High$124.04

HAE is currently trading at $121.69, placing it 96.9% of the way from its 52-week low of $48.55 to its 52-week high of $124.04. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Haemonetics Corporation (HAE)?

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Haemonetics Corporation Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	3009
Exchange	NYSE
Company Website	https://www.haemonetics.com

How to Buy Haemonetics Corporation (HAE) Stock on MEXC

Eligible investors can buy real shares of Haemonetics Corporation (HAE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for HAE and Place Your Order

Open the RealStocks trading page and search for HAE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Haemonetics Corporation (HAE) stock price today?

Haemonetics Corporation (HAE) is currently trading at $ 121.69, down 0.30% ($0.37) from the previous close of $ 122.06. Intraday prices update in real time during regular trading hours.

2.Is HAE stock going up or down today?

As of 2026-10-13 21:24:00, HAE is trading at $ 121.69, down 0.30% ($0.37) from its previous close of $ 122.06. The stock has traded between $ 10.85 and $ 142.11 during today’s regular session. Past price movements do not guarantee future results.

3.What is HAE pre-market price?

As of 2026-10-13 21:24:00, HAE is trading at $ 123.54 in pre-market trading, up 1.21% ($1.48) from the previous close of $ 122.06. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is HAE after-hours price?

As of 2026-10-13 21:24:00, HAE is trading at $ 121.68 in after-hours trading, down 0.32% ($0.39) from the regular-session close of $ 122.06. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is HAE stock trading now?

HAE trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does HAE sit relative to its 52-week high and low?

Over the past 52 weeks, HAE has traded between a low of $ 48.55 and a high of $ 124.04. At $ 121.69, the stock is positioned 96.9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Haemonetics Corporation in?

Haemonetics Corporation (HAE) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Haemonetics Corporation's market capitalisation and where is it listed?

Haemonetics Corporation is listed on the NYSE exchange with a market capitalisation of $ 5.40B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is HAE valued in terms of P/E ratio and EPS?

HAE trades at a P/E ratio of 57.68, based on trailing-twelve-month EPS of $ 2.12. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Haemonetics Corporation pay a dividend?

Haemonetics Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.